                            NIH Public Access
                            Author Manuscript
                            Anal Biochem. Author manuscript; available PMC 2010 November 1.
                           Published final edited form 
NIH-PA Author Manuscript




                            Anal Biochem. 2009 November 1; 394(1): 39–47. doi:10.1016/j.ab.2009.06.037.



                           homogenous resonance energy transfer assay                            phosphopantetheinyl transferase

                           Timothy L. Foley Michael D. Burkart*
                           Department Chemistry & Biochemistry; University California, San Diego; 9500 Gilman Drive;
                           La Jolla, CA 92093-0358. telephone (85)534-5673, fax (858) 882-1174

                           Abstract
                                Phosphopantetheinyl transferase plays essential role activating fatty acid, polyketide                                 nonribosomal peptide biosynthetic pathways, catalyzing covalent attachment 4’-
                                phosphopantetheinyl group conserved residue carrier protein domains. enzyme                                 validated essential gene primary metabolism presents target identification
NIH-PA Author Manuscript




                                antibiotics new mode action. report development homogenous resonance
                                energy transfer assay utilizing fluorescent coenzyme derivatives surrogate peptide substrate
                                serve identify inhibitors enzyme class. assay lays blueprint translation
                                techniques transferase enzymes accept fluorescent substrate analogues.


                           Keywords
                                phosphopantetheinyl transferase; assay development; high throughput screen; FRET assay;
                                fluorescent analogue; Coenzyme  Acyl carrier protein; Peptidyl carrier protein; secondary
                                metabolism


                           Introduction
                                              unifying characteristic biosynthesis fatty acid, non-ribosomal peptide,                                               polyketide compounds tethering nascent polymer small carrier protein domains
                                              synthases thioester linkage phosphopantetheinyl (4’-PP) arm. 4’-
                                              PP installed proteins post-translationally coenzyme (CoA) 2 conserved
NIH-PA Author Manuscript




                                              serine residue action phosphopantetheinyl transferase (PPTase) enzymes, converting
                                              apo- 1 holo- 4 form (Fig. 1). modification essential synthase
                                              activity, ablation PPTase gene precludes natural product production [1–4],                                               case fatty acid biosynthesis, renders organism unviable [3–5]. bacteria,                                               exist major classes enzymes PPTase superfamily: AcpS-type Sfp-
                                              type [1]. Grouping designations based primary sequence,                                               canonical representatives, AcpS Escherichia coli Sfp Bacillus subtilis, structurally
                                              distinct [6; 7].

                                              demonstrated acpS essential E. coli gene [8; 9], validating                                               target inhibitor development potential treat multi-drug resistance.  

                            correspondence addressed: mburkart@ucsd.edu.
                           Publisher's Disclaimer: PDF file unedited manuscript accepted publication. service customers
                           providing early version manuscript. manuscript undergo copyediting, typesetting, review resulting
                           proof published final citable form. note production process errors discovered                            affect content, legal disclaimers apply journal pertain.
                            Foley Burkart                                                                                                 Page 2


                                               number groups begun focused programs develop AcpS inhibitors [10–14]                                                candidates recently discussed [10–12]. addition fatty acids, number
                                               compounds produced 4’-PP dependent pathways identified NIH-PA Author Manuscript




                                               virulence factors, disruption biosynthesis received attention new
                                               angle therapeutic development [15–19]. intrigued central role                                                phosphopantetheinylation metabolic pathways, interested studying                                                potential effects PPTase inhibitors coordinate attenuation numerous
                                               aspects pathogenicity.

                                               AcpS-directed inhibitor development reported [10–14], work generally
                                               omitted screening protocols. described method utilizes homogenous time-resolved
                                               fluorescence resonance energy transfer (HT-RF) means activity determination [11].
                                               replication technique capabilities limitations imposed                                                instrumentation, desired use readily available affordable biochemical
                                               reagents. report development homogenous fluorescence resonance energy
                                               transfer (FRET) screen canonical PPTase representatives, AcpS Sfp.                                                method simple, requiring addition reagents reaction wells microtiter plate,
                                               validated process identify inhibitors enzymes. Furthermore,                                                details led successful development screen, serve blueprint
                                               assay design transferase enzymes accept reporter-modified substrate analogues.
NIH-PA Author Manuscript




                              Materials Methods
                              General
                                               7-dimethylamino-4-methyl-coumarin-3-maleimide (DACM) N,N,N’,N’-
                                               tetramethylrhodamine-5-maleimide (TAMRA) purchased Invitrogen Corporation
                                               (Carlsbad, CA). Coenzyme trilithium salt purchased EMD biochemicals (San
                                               Diego, CA). 3’-phosphoadenosine-5’-phosphate disodium salt (PAP), 4-(2-hydroxyethyl)-1-
                                               piperazine ethanesulfonic acid (HEPES), dimethylsulfoxide (DMSO, Hybri-Max grade),                                                fluorescein-isothiocyanate isomer (FITC) purchased Sigma (Saint Louis, MO).
                                               Concentrations fluorescently labeled reagents quantified UV-VIS spectroscopy
                                               Agilent 8354 diode array spectrophotometer (Agilent Technologies, Santa Clara, CA)
                                               using following extinction coefficients: DACM: 23,000 cm−1 M−1, FITC: 77,000 cm−1
                                               M−1, TAMRA: 95,000 cm−1 M−1.

                              Enzyme expression & Purification
                                               Sfp expressed purified described previously [2]. enzyme concentrated                                                40 mg/mL, diluted equal volume 75   glycerol, stored 100 µL aliqouts                                                −80°C. routine use, stock (20 mg/mL, 765 µM) diluted 1 mg/mL Sfp storage
NIH-PA Author Manuscript




                                               buffer (50 mM NaHEPES, 120 mM NaCl, 33   v/v glycerol) supplemented 0.1  w/v
                                               BSA stored −20°C. conditions, noticeable reduction                                                enzymatic activity storage periods longer 6 months.

                                               E. coli AcpS expressed purified native protein pDPJ according published
                                               procedures [20]. protein concentration final preparation adjusted 10 mg/mL
                                               addition 2X storage buffer, equal volume glycerol added 3 portions, aliquots
                                               stored −80°C. routine work, single tubes (200 µL portions) stored −20°C,                                                degradation enzymatic activity observed 1 year storage.

                              Synthesis assay components
                                               exploratory quantity (ca. 8 mg) fluorescein-5-isothiocyanate-modified YbbR peptide
                                               (FITC-YbbR) 8 (sequence: Fluorescein-Ahx-DSLEFIASKLA-OH) initially purchased


                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                            Page 3


                                               GL Biochem (Shanghai, China). final screen evaluation, peptide prepared
                                               0.2 mmol scale using automated solid phase peptide synthesizer (Applied Biosystems
                                               Pioneer) using standard 9-fluorenylmethyloxycarbonyl (FMOC) chemistry 2-(1H-7-
NIH-PA Author Manuscript




                                               Azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU) activation
                                               (Fig. 3A) [21]. sequence appended N-terminal N-FMOC-ε-aminocaproic acid
                                               spacer, deprotected, coupled overnight FITC. Following cleavage solid
                                               support, product HPLC purified yield 84 mg FITC-YbbR 8 identity verified
                                               ESI-MS.

                                               Fluorescent reporter CoA (mCoA) analogues 11 12 prepared reaction reduced
                                               CoA trilithium salt 2 (1 mg/mL 50 mM NaH2PO4, pH 7.4) 1.1 equivalents maleimide
                                               bearing probe 9 10, respectively  dissolved 1 mg/mL methanol) (Fig. 3B).                                                reaction followed completion HPLC, determined disappearance CoA peak.
                                               Excess 9 10 removed extraction times ethyl acetate dichloromethane,
                                               respectively. resultant aqueous phase placed vacuum (< 2 mm/Hg) 2h                                                remove residual organic solvent. purity mCoA analogues 11 12 verified                                                >95  HPLC.

                              Kinetic evaluation fluorescent substrates
                                               Kinetic parameters FITC-YbbR 8 TAMRA-mCoA 12 determined HPLC.
                                               Reactions conducted final volume 50 µL buffer containing 10 mM MgCl2,
NIH-PA Author Manuscript




                                               50 mM Na-HEPES, pH 7.6, 0.1 mg/mL BSA. Reactions initiated addition 0.5
                                               µM enzyme, allowed progress 15 minutes, quenched addition 50 µL 50 mM
                                               sodium ethylenediaminetetraacetic acid, pH 8.0. reaction mixtures separated                                                reversed phase chromatography Agilent 1100 instrument fitted diode array
                                               detector (Agilent Technologies, Santa Clara, CA) using OD5 C18 column (250 × 4.6 mm,
                                               product number 9575, Burdick & Jackson, Morristown, NJ). separation performed
                                               following conditions: Buffer  10 mM ammonium acetate, Buffer B: Acetonitrile,
                                               flow rate: 1.5 mL/min. injection, run initiated 2 minute isocratic flow 10 
                                               Buffer B, followed sample elution 10 minute linear gradient 10  60  Buffer
                                               B. column regenerated 2 minute isocratic flow 100  Buffer B,                                                column equilibrated 10  Buffer B.

                              Fluorescence spectroscopy
                                               Steady state single sample fluorescence spectra recorded QuantaMaster 2000
                                               spectrofluorometer (Photon Technologies International, Princeton, NJ), using excitation                                                emission slit widths 4 nm integration times 0.1 sec.
NIH-PA Author Manuscript




                              FRET screen conditions
                                               PAP parent inhibitor plates dissolving compound dry DMSO                                                concentration 10 mM serial diluting (2-fold) DMSO. final protocol (Table
                                               1) follows: 2.5 µL parent DMSO solutions  DMSO negative control)                                                transferred individual wells black polystyrene 96 plate (Costar # 3694) followed
                                               37.5 µL 1.33 X Enzyme solution [16.62 nM Sfp 66.6 nM AcpS 1.33 X PPTase
                                               assay buffer (66 mM Na-HEPES, 13.3 mM MgCl2, 1.33 mg/mL BSA, pH 7.6). Reactions                                                initiated addition 10 µL 5X reagent solution (50 µM TAMRA-mCoA 12, 25 µM
                                               FITC-YbbR 8, 10 mM NaH2PO4, pH 7.0). reaction monitored continuously (cycle
                                               time 2 minutes) 15 cycles Perkin Elmer HTS7000plus microtiter plate reader                                                excitation filter λ = 485 nm, emission filter λ = 535 nm.




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                              Page 4


                              Data analysis
                                               Kinetic data processed Microsoft Excel. Assay statistics evaluated according
                                               standard equations [22]. Plotting nonlinear regression performed GraphPad
NIH-PA Author Manuscript




                                               Prism version 5.00 (GraphPad  La Jolla, CA), IC50 curves fit 
                                               parameter dose response equation using ordinary  squares) setting. cases, error
                                               bars reported error values represent standard deviation. Molecular graphics images
                                               (Fig. 1 & Fig. 2) renditions apo-actinorhodin acyl carrier protein (PDB identifier:
                                               2K0Y) generated using UCSF Chimera package [23].

                              Results & Discussion
                              Design high-throughput PPTase assay
                                               Traditionally, PPTase bioassays conducted low throughput manner,                                                monitoring radiolabel incorporation precipitated protein mass [3H]-CoA [4]                                                HPLC separation apo- holo-states carrier protein substrate [3]. systems
                                               utilize centrifugation chromatographic separations, respectively, readily
                                               amenable high throughput screening. designing high throughput screen PPTase
                                               activity, desired allow direct monitoring reaction progress                                                eliminate probability false-positive hits arrive inhibition coupled enzyme
                                               systems. accomplish  chose exploit synthetic aspect PPTase reaction
NIH-PA Author Manuscript




                                               conjunction fluorescent reporter-CoA (mCoA) technology developed previously                                                laboratory [24].  fluorophore-appended carrier protein domains/mimics 5
                                               generate FRET signal conversion thiol-blocked crypto-form 7 modification
                                               mCoA 6 analogs PPTase (Fig. 2).

                              Fluorescent probe selection substrate synthesis
                                               chose make fluorescein-5-isothiocyanate (FITC) modification protein-based
                                               substrate, fluorophore possesses absorption emission centered visible light
                                               spectrum, allowing function FRET donor acceptor, depending identity
                                               compounds chosen mCoA 6 preparation (Fig. 2). allow probe                                                modes FRET singly prepared pool reagent. turning select carrier protein
                                               domain function acceptor substrate, initially considered E. coli fatty acid
                                               synthase acyl carrier protein (ACP) candidate, previous reports note ACP contains
                                               single tyrosine residue present C-terminus α-helix 3 modification residue
                                               dansyl-moiety does hinder function [25;26]. protocol                                                tyrosine-modifying techniques [27;28] provide low yields fluorescein-modified proteins
                                               insolubility FITC derivatives low pH reaction conditions (data                                                shown), purification labeled material insufficient needs.
NIH-PA Author Manuscript




                                               Subsequently, chose investigate use residue YbbR peptide (sequence
                                               H-DSKLEFIASKLA-OH) identified Yin et al. undergoes modification PPTases,
                                               serving ACP surrogate [29]. choice strengthened fact solid phase
                                               peptide synthesis (SPPS) allows access large quantities uniformly labeled material,                                                crucial requirement FRET applications, avoids potential batch batch
                                               variability. selecting placement label, noted YbbR isolated                                                collection N-terminal extensions consensus, suggesting site modification                                                abrogate activity.  chose attach FITC YbbR consensus 6-
                                               aminocaproic acid spacer unit sufficiently distance molecule central motif (Fig.
                                               3A) impart number freely rotatable bonds, ensuring random spatial orientation
                                               FRET-pair assembly (vide infra).




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                             Page 5


                                               selecting complimentary probes containing modest spectral overlap FITC mCoA
                                               6 production, sought maleimide-bearing compounds amenable organic
                                               extraction reaction CoA (Fig. 3B), circumvent HPLC purification; NIH-PA Author Manuscript




                                               characteristic make procedure easily scaleable high screening volume
                                               application. mind, dimethylaminocoumarin (DACM) 9 tetramethylrhodamine
                                               (TAMRA) 10 chosen used prepare DACM-mCoA 11 TAMRA-mCoA 12 (Fig.
                                               3B) evaluated FRET donor (Fig. 4A) FRET acceptor (Fig. 4E), respectively.

                              HPLC analysis labeled substrates
                                               labeled substrates evaluated HPLC probe effects modification                                                substrates kinetic parameters displayed enzymes. Evaluation                                                FITC-YbbR 8 AcpS Sfp, saturating concentration CoA 2 returned Km values
                                               86 101 µM Kcat values 4.4 12.1 µM, respectively. agreement
                                               values previously determined unmodified substrate (Km values 200 123
                                               µM AcpS Sfp, respectively) [29;30]. Additionally, kinetic parameters TAMRA-
                                               mCoA 12 determined saturating concentration FITC-YbbR 8 gave Km values
                                               22 6 µM AcpS Sfp, Kcat values 3.2 8.9, respectively.                                                 values agreement previously determined parameters [29;30]                                                demonstrate modifications substrates tolerated enzymes.

                              Determination Förster Radius
NIH-PA Author Manuscript




                                               order assess viability donor acceptor substrates chosen, sought                                                determine theoretical Forster’s radius, R0, pairs. value, distance                                                transfer efficiency 50 , related donor quantum yield ФD, relative orientation                                                donor acceptor transition dipoles κ, J(λ), overlap integral donor emission
                                               FD absorption acceptor εA [31]:



                                                                                                                                            (1)



                                               κ value 2/3 assumed corresponds random orientation fluorophores
                                               space, given linked numerous freely rotatable bonds. η, index                                                refraction medium, assumed 1.44 biological samples [31] NA, avagadro’s
                                               number, constant, leaving R0 determined ФD, J(λ). Quantum yields                                                fluorophores previously determined [32], J(λ) expressed 

                                                                                                                                            (2)
NIH-PA Author Manuscript




                                               Simple equations written FD(λ) εA(λ),  J(λ) calculated                                                summation [33]:



                                                                                                                                            (3)



                                               Absorption emission spectra recorded conjugated substrates 8, 11                                                12 (Fig. 4B & F) summation values wavelength according Eq. (3) use
                                               J(λ) values Eq. (1) gave Förster’s radii 38 Å 56 Å DACM-FITC (Fig.
                                               4A) TAMRA-FITC pairs (Fig. 4E), respectively.


                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                              Page 6


                              Photophysical evaluation phosphopantetheinylated peptide efficiency transfer
                              determination
                                               theoretical Förster’s radii, mathematically calculated maximum distance NIH-PA Author Manuscript




                                               fluorophores achieve crypto-FITC-YbbR product (exemplified 7, Fig. 2)
                                               summation average bond lengths, determined 42 Å (radius, r, 21 Å)                                                rigid linear extension occur. suggests high theoretical FRET efficiency, E,
                                               strictly related radius separating fluorophores, r, 


                                                                                                                                             (4)



                                               rapid decay E r exceeds R0. Using R0 values determined Eq. (1)                                                calculated r 21Å; Eq. (4) gives theoretical E values 97   99   DACM-
                                               FITC TAMRA-FITC pairs, respectively.  r exists distribution                                                number freely rotatable bonds, transfer efficiency experimentally
                                               determined measurement donor fluorescence absence (FD) presence (FDA)                                                acceptor fitting Eq. (5) experimental data:
NIH-PA Author Manuscript




                                                                                                                                             (5)



                                               Reactions set mCoA analogues 11 12, Sfp, FITC-YbbR 8 followed
                                               completion HPLC. corresponding crypto-FITC-YbbR 7 peptides isolated
                                               semi-preparative HPLC. products used prepare equimolar mixtures                                                probes varying degrees modification. Fluorescent emission spectra mixtures
                                               recorded (Fig. 4C & G). Analysis data (Fig. 4D & H) Eq. (5) yields efficiency
                                               transfers 0.82 0.99 DACM-FITC (Fig. 4A) TAMRA-FITC (Fig. 4E) pairs,
                                               respectively.

                              Mode observation
                                               Data Fig. 4 (C & G) informative regard mode monitoring                                                biochemical  FRET pairs offer flexibility assembly detected                                                quench donor emission  arrows) sensitization acceptor fluorescence
                                               shorter excitation wavelengths  arrows). Evaluation data systems shows                                                greater response quenching mode, 5-fold 10-fold reduction donor
                                               fluorescence conversion crypto-FITC-YbbR 7 DACM-FITC TAMRA-
NIH-PA Author Manuscript




                                               FITC pairs, respectively. Evaluation acceptor sensitized emission shorter excitation
                                               wavelengths showed increase 2-fold complete conversion, indicating                                                greater signal background ratio monitoring quench donor
                                               fluorescence. screen function optimally substrate-consumption assay.

                                               FRET systems, TAMRA-mCoA probe 12 possessed better FRET characteristics
                                                e. attenuation donor fluorescence complete conversion) chosen                                                carried forward screen implementation.

                              Determination screen conditions
                                               arrived initial assay conditions based requirement end point need
                                               complete attenuation donor fluorescence; requiring TAMRA-mCoA 12 present                                                excess FITC-YbbR 8. mind, probed linearity detector response                                                respect FITC-YbbR 8 concentration. identify maximal concentration

                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                              Page 7


                                               obtained direct correlations relative fluorescence units                                                substrate concentration obscured inner filter effect, phenomenon                                                incedent light irradiated sample absorbed does sufficiently transition NIH-PA Author Manuscript




                                               target molecules excited state. plate reader (Perkin Elmer HTS7000)                                                delineation occur concentrations exceeding 10 µM, chose hold FITC-YbbR
                                               8 concentration 5 µM.

                                               sought determine effects increasing concentration TAMRA-mCoA
                                               12 FITC-YbbR 8 signal. purpose analysis acceptably high
                                               concentration TAMRA-mCoA 12 did impart effect FITC-YbbR 8 emission,
                                               displays absorption FITC-YbbR 8 excitation wavelengths. signal
                                               maintained concentrations 12.5 µM arrived final concentration                                                screen TAMRA-mCoA 12 10 µM.

                              Assay optimization: Requirement BSA enzyme stability
                                               screen developed initiating reactions 96 plates varied enzyme
                                               concentration. experiments monitored continuously using standard fluorescein
                                               optics, analysis progress curves revealed reaction rate did follow linearly
                                               respect enzyme concentration. identified complication time-
                                               dependent inactivation enzyme using Selwyn’s method [34] (data shown). number
                                               reaction additives, including buffer salt composition, ionic strength, detergents NIH-PA Author Manuscript




                                               screened attempt stabilize enzyme, inclusion bovine serum
                                               albumin (BSA) concentration 1 mg/mL (15 µM) stabilized enzyme eliminated
                                               complication.

                                               modification, stable reaction progress plots observed (Fig. 5A & C)                                                displayed linear relationship rate enzyme concentration (Fig. 5B & D).                                                data, determined optimal enzyme concentrations 50 12.5 nM AcpS                                                Sfp, respectively, based obtaining complete progress curve terminating approximately
                                               30  substrate consumption 30 minute time interval (vide infra). noteworthy                                                inclusion BSA traditionally considered unattractive screening campaign,
                                               carrier provides excellent source amine thiol moieties serve repress
                                               inhibition enzyme nonspecific electrophilic species present diverse compound
                                               libraries.

                              DMSO tolerance
                                               compound libraries stocked solutions DMSO, sought evaluate                                                tolerance screen organic solvent. Inclusion organic solvent reaction
NIH-PA Author Manuscript




                                               caused immediate 10  increase RFU signal substrate mixture did                                                deteriorate observed rate reaching concentration greater 10  total volume (data
                                               shown). routine screening conditions, maintained final DMSO concentration
                                               5  v/v.

                              Progress curve analysis signal statistics
                                               final assay conditions hand, screening protocol developed presented                                                Table 1. Following protocol, recorded progress curves analysed data
                                               statistically determine appropriate time analysis. known inhibitors PPTases
                                               commercially available, enzyme-free reaction used fully inhibited
                                               (negative) control. Analysis data (presented Fig. 6A & B) demonstrated assay
                                               performance relied heavily substrate consumption allowed occur,
                                               parameter values better consumption (Table 2). 
                                               excessive substrate consumption lead erroneous determination inhibition


                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                             Page 8


                                               characteristics [35], progression ~20  (Table 2, boxed values) chosen balance
                                               conditions minimum substrate consumed assay statistics reached
                                               acceptable values, including  values 0.7, signal noise 20 (Table 2).
NIH-PA Author Manuscript




                                               Subsequently, experiment repeated separate days assess robustness                                                method, data presented Table 3.  factor [36] used evaluate
                                               suitability screening method high throughput implementation, values greater
                                               0.5 considered satisfactory. assay performed  gave  values 0.72
                                               ± 0.01 0.75 ± 0.02 Sfp AcpS, respectively.

                              Screen validation inhibitor identification
                                               demonstrate ability screen identify inhibitors PPTases, evaluated                                                effects product inhibition 3’-phosphoadenosine-5’-phosphate (PAP) 3 (Fig. 1),                                                nucleotide product released enzyme, utilized McAllister et al. studies                                                reaction mechanism AcpS [13]. PAP serial diluted (2-fold) concentration                                                10 mM DMSO stocked polypropylene plates, evaluated assay                                                enzymes separate days (Fig. 7), demonstrate reproducibility screen.
                                               method proved yield consistent inhibition curves, IC50 values 12.3 ± 1.1 µM                                                92 ± 6 µM Sfp AcpS, respectively; Hill coefficients analyses −1.06 ±
                                               0.09 Sfp −0.98 ± 0.11 AcpS. Taken  data support suitability                                                method determine inhibitory characteristics compounds PPTase enzymes.
NIH-PA Author Manuscript




                              Conclusions
                                               summary, developed homogenous screen PPTase requires minimum
                                               number liquid handling steps, meets criteria set forth NIH Chemical Genomics
                                               Center acceptable automation [37]. Importantly, method utilizes simple reagents
                                               prepared traditional techniques [24;38], pure chemical entities                                                require interbatch standardization, luxury afforded complex biochemical
                                               reagents. anticipated method used evaluate crossreactivity                                                currently known AcpS inhibitors, identify new inhibitor architectures Sfp AcpS,
                                               work currently progress.

                              Abbreviations used
                                               4’-PP, 4’-phosphopantetheine
                                               ACP, acyl carrier protein
                                               CoA, coenzyme                                                mCoA, modified-coenzyme NIH-PA Author Manuscript




                                               PPTase, phosphopantetheinyl transferase
                                               FRET, fluorescence resonance energy transfer
                                               DACM, 7-dimethylamino-4-methyl-coumarin-3-maleimide
                                               TAMRA, tetrametylrhodamine-5-maleimide
                                               PAP, 3’-phosphoadeosine-5’-phosphate
                                               UV-VIS, ultraviolet-visible
                                               FITC, fluorescein-5-isothiocyanate
                                               HEPES, 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid
                                               BSA, bovine serum albumen
                                               FMOC, 9-Fluorenylmethyloxycarbonyl
                                               HATU, 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate
                                               DMSO, dimethyl sulfoxide
                                               RFU, relative fluorescence unit



                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                                          Page 9


                              Acknowledgements
                                               work funded NIH R01GM075797 1R03MH083266. thank Christopher T. Walsh (Harvard
NIH-PA Author Manuscript




                                               Medical School) plasmids containing Sfp AcpS expression systems, Elizabeth  Komives guidance
                                               assistance peptide synthesis, Adam Yasgar Anton Simeonov (NIH Chemical Genomics Center)                                                helpful discussions.


                              References
                                               1. Lambalot RH, Gehring  Flugel RS, Zuber P, LaCelle M, Marahiel MA, Reid R, Khosla C, Walsh
                                                  CT. new enzyme superfamily - phosphopantetheinyl transferases. Chem Biol 1996;3:923–936.
                                                  [PubMed: 8939709]
                                               2. Quadri LE, Weinreb PH, Lei M, Nakano MM, Zuber P, Walsh CT. Characterization Sfp Bacillus
                                                  subtilis phosphopantetheinyl transferase peptidyl carrier protein domains peptide synthetases.
                                                  Biochemistry 1998;37:1585–1595. [PubMed: 9484229]
                                               3. Barekzi N, Joshi S, Irwin S, Ontl T, Schweizer HP. Genetic characterization encoding                                                   multifunctional phosphopantetheinyl transferase Pseudomonas aeruginosa. Microbiology
                                                  2004;150:795–803. [PubMed: 15073290]
                                               4. Finking R, Solsbacher J, Konz D, Schobert M, Schafer  Jahn D, Marahiel MA. Characterization                                                   new type phosphopantetheinyl transferase fatty acid siderophore synthesis Pseudomonas
                                                  aeruginosa. J Biol Chem 2002;277:50293–50302. [PubMed: 12381736]
                                               5. Lambalot RH, Walsh CT. Cloning, overproduction, characterization Escherichia coli holo-
NIH-PA Author Manuscript




                                                  acyl carrier protein synthase. J Biol Chem 1995;270:24658–24661. [PubMed: 7559576]
                                               6. Parris KD, Lin L, Tam  Mathew R, Hixon J, Stahl M, Fritz CC, Seehra J, Somers WS. Crystal
                                                  structures substrate binding Bacillus subtilis holo-(acyl carrier protein) synthase reveal novel
                                                  trimeric arrangement molecules resulting active sites. Structure Folding & Design
                                                  2000;8:883–895. [PubMed: 10997907]
                                               7. Reuter K, Mofid MR, Marahiel MA, Ficner R. Crystal structure surfactin synthetase-activating
                                                  enzyme Sfp: prototype 4 ‘-phosphopantetheinyl transferase superfamily. Embo Journal
                                                  1999;18:6823–6831. [PubMed: 10581256]
                                               8. Lam HM, Tancula E, Dempsey WB, Winkler  Suppression Insertions Complex Pdxj
                                                  Operon Escherichia-Coli K-12 Ion Mutations. Journal Bacteriology
                                                  1992;174:1554–1567. [PubMed: 1537800]
                                               9. Takiff  Baker T, Copeland T, Chen SM, Court DL. Locating Essential Escherichia-Coli Genes                                                   Using Mini-Tn10 Transposons - Pdxj Operon. Journal Bacteriology 1992;174:1544–1553.
                                                  [PubMed: 1537799]
                                               10. Chu M, Mierzwa R, Xu L, Yang SW, L, Patel M, Stafford J, Macinga D, Black T, Chan TM,
                                                    Gullo V. Structure elucidation Sch 538415 novel acyl carrier protein synthase inhibitor                                                     microorganism. Bioorg Med Chem Lett 2003;13:3827–3829. [PubMed: 14552789]
                                               11. Gilbert  Kirisits M, Toy P, Nunn DS, Failli  Dushin  Novikova E, Petersen PJ, Joseph-
                                                    McCarthy D, McFadyen  Fritz CC. Anthranilate 4H–oxazol-5-ones: novel small molecule
NIH-PA Author Manuscript




                                                    antibacterial acyl carrier protein synthase (AcpS) inhibitors. Bioorg Med Chem Lett 2004;14:37–41.
                                                    [PubMed: 14684293]
                                               12. Joseph-McCarthy D, Parris K, Huang  Failli  Quagliato D, Dushin  Novikova E, Severina
                                                    E, Tuckman M, Petersen PJ, Dean C, Fritz CC, Meshulam T, DeCenzo M, Dick L, McFadyen IJ,
                                                    Somers WS, Lovering F, Gilbert  Use structure-based drug design approaches obtain novel
                                                    anthranilic acid acyl carrier protein synthase inhibitors. J Med Chem 2005;48:7960–7969. [PubMed:
                                                    16335920]
                                               13. McAllister KA, Peery RB, Meier TI, Fischl  Zhao G. Biochemical molecular analyses                                                     Streptococcus pneumoniae acyl carrier protein synthase enzyme essential fatty acid
                                                    biosynthesis. J Biol Chem 2000;275:30864–30872. [PubMed: 10903317]
                                               14. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs bad bugs: confronting challenges
                                                    antibacterial discovery. Nat Rev Drug Discov 2007;6:29–40. [PubMed: 17159923]
                                               15. Neres J, Labello NP, Somu RV, Boshoff HI, Wilson DJ, Vannada J, Chen L, Barry CE, Bennett EM,
                                                    Aldrich CC. Inhibition siderophore biosynthesis Mycobacterium tuberculosis nucleoside


                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                                      Page 10


                                                    bisubstrate analogues: Structure-activity relationships nucleobase domain 5 ‘-O-[N-(salicyl)
                                                    sulfamoyl]adenosine. Journal Medicinal Chemistry 2008;51:5349–5370. [PubMed: 18690677]
                                               16. Stirrett KL, Ferreras JA, Jayaprakash V, Sinha BN, Ren T, Quadri LEN. Small molecules NIH-PA Author Manuscript




                                                    structural similarities siderophores novel antimicrobials Mycobacterium tuberculosis
                                                    Yersinia pestis. Bioorganic & Medicinal Chemistry Letters 2008;18:2662–2668. [PubMed:
                                                    18394884]
                                               17. Ferreras JA, Stirrett KL, Lu XQ, Ryu JS, Soll CE, Tan DS, Quadri LEN. Mycobacterial phenolic
                                                    glycolipid virulence factor biosynthesis: Mechanism small-molecule inhibition polyketide
                                                    chain initiation. Chemistry & Biology 2008;15:51–61. [PubMed: 18158259]
                                               18. Cisar JS, Ferreras JA, Soni RK, Quadri LEN, Tan DS. Exploiting ligand conformation selective
                                                    inhibition non-ribosomal peptide synthetase amino acid adenylation designed macrocyclic
                                                    small molecules. Journal American Chemical Society 2007;1297752-+
                                               19. Meier JL, Barrows-Yano T, Foley TL, Wike CL, Burkart MD. unusual macrocycle forming
                                                    thioesterase mycolactone. Molecular Biosystems 2008;4:663–671. [PubMed: 18493665]
                                               20. Lambalot RH, Walsh CT. Holo-[acyl-carrier-protein] synthase Escherichia coli, Vitamins                                                     Coenzymes. 1997;(Pt :254–262.
                                               21. Glover KJ, Martini PM, Vold RR, Komives EA. Preparation insoluble transmembrane peptides:
                                                    Glycophorin  prion (110–137 FGFR (368–397). Analytical Biochemistry 1999;272:270–274.
                                                    [PubMed: 10415099]
                                               22. Inglese J, Johnson RL, Simeonov  Xia MH, Zheng W, Austin CP, Auld DS. High-throughput
                                                    screening assays identification chemical probes. Nature Chemical Biology 2007;3:466–
NIH-PA Author Manuscript




                                                    479.
                                               23. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF
                                                    chimera - visualization exploratory research analysis. Journal Computational
                                                    Chemistry 2004;25:1605–1612. [PubMed: 15264254]
                                               24. La Clair JJ, Foley TL, Schegg TR, Regan CM, Burkart MD. Manipulation carrier proteins                                                     antibiotic biosynthesis. Chem Biol 2004;11:195–201. [PubMed: 15123281]
                                               25. Haas JA, Frederick MA, Fox BG. Chemical posttranslational modification Escherichia coli
                                                    acyl carrier protein preparation dansyl-acyl carrier proteins’. Protein Expression                                                     Purification 2000;20:274–284. [PubMed: 11049751]
                                               26. Blommel PG, Fox BG. Fluorescence anisotropy assay proteolysis specifically labeled fusion
                                                    proteins. Analytical Biochemistry 2005;336:75–86. [PubMed: 15582561]
                                               27. Joshi NS, Whitaker LR, Francis MB. component Mannich-type reaction selective tyrosine
                                                    bioconjugation. Journal American Chemical Society 2004;126:15942–15943. [PubMed:
                                                    15584710]
                                               28. Schlick TL, Ding ZB, Kovacs EW, Francis MB. Dual-surface modification tobacco mosaic
                                                    virus. Journal American Chemical Society 2005;127:3718–3723. [PubMed: 15771505]
                                               29. Yin J, Straight PD, McLoughlin SM, Zhou  Lin AJ, Golan  Kelleher NL, Kolter R, Walsh CT.
                                                    Genetically encoded short peptide tag versatile protein labeling Sfp phosphopantetheinyl
                                                    transferase. Proc Natl Acad Sci U S 2005;102:15815–15820. [PubMed: 16236721]
NIH-PA Author Manuscript




                                               30. Zhou  Cironi P, Lin AJ, Xu YQ, Hrvatin S, Golan  Silver PA, Walsh CT, Yin J. Genetically
                                                    encoded short peptide tags orthogonal protein labeling sfp AcpS phosphopantetheinyl
                                                    transferases. Acs Chemical Biology 2007;2:337–346. [PubMed: 17465518]
                                               31. Lakowicz, JR. Principles fluorescence spectroscopy. New York: Kluwer Academic/Plenum; 1999.
                                               32. Machida M, Ushijima N, Machida MI, Kanaoka Y. Fluorescent Thiol Reagents.9 N-(7-
                                                    Dimethylamino-4-Methyl-Coumariny)Maleimides (Dacm) - Novel Fluorescent Thiol Reagents.
                                                    Chemical & Pharmaceutical Bulletin 1975;23:1385–1386.
                                               33. Campbell, ID.; Dwek, RA.; Dwek, RA. Biological spectroscopy. Menlo Park, Calif: Benjamin/
                                                    Cummings Pub.  1984.
                                               34. Selwyn MJ. Simple Test Inactivation Enzyme Assay. Biochimica Et Biophysica
                                                    Acta 1965;105:193–194. [PubMed: 4221326]
                                               35. Wu G, Yuan Y, Hodge CN. Determining appropriate substrate conversion enzymatic assays                                                     high-throughput screening. Journal Biomolecular Screening 2003;8:694–700. [PubMed:
                                                    14711395]


                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                                Page 11


                                               36. Zhang JH, Chung TDY, Oldenburg KR. simple statistical parameter use evaluation                                                    validation high throughput screening assays. Journal Biomolecular Screening 1999;4:67–73.
                                                   [PubMed: 10838414]
NIH-PA Author Manuscript




                                               37. NCGC, Assay Guidance Criteria. 2009.
                                                   http://www.ncgc.nih.gov/guidance/HTS_Assay_Guidance_Criteria.html March 31 2009
                                               38. Wellings DA, Atherton E. Standard Fmoc protocols. Methods Enzymology 1997;289:44–67.
                                                   [PubMed: 9353717]
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                       Page 12
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               Fig. 1. Post-translational modification carrier proteins
                                               translated apo-carrier proteins 1 coenzyme 2 react PPTase generate 3’-
                                               phosphoadenosine-5’-phosphate (PAP) 3 holo-carrier proteins 4.
NIH-PA Author Manuscript




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                              Page 13
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               Fig. 2. Fluorescence resonance energy transfer assay phosphopantetheinyl transferase
                                               Action PPTase fluorescently labeled acceptor substrate 5, conjunction                                                fluorphore-modified coenzyme analogue (mCoA) 6, assembles FRET pair conversion
                                               thiol-blocked crypto-acceptor substrate 7. assembly FRET pair NIH-PA Author Manuscript




                                               detected fluorescence microplate reader.




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                       Page 14
NIH-PA Author Manuscript




                                               Fig. 3. Synthesis assay components
                                                 Beginning L-alanine loaded polystyrene resin, standard SPPS procedures afford NIH-PA Author Manuscript




                                               YbbR sequence appended ε-aminocaproic acid residue. Reaction FITC, followed
                                               cleavage HPLC purification gives FITC-YbbR peptide substrate 8. (B) CoA 2                                                reacted maleimide bearing probes 9 10 produce fluorescent mCoA derivatives
                                               11 12, respectively.
NIH-PA Author Manuscript




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                            Page 15
NIH-PA Author Manuscript




                                               Fig. 4. Probe selection photophysical evaluation crypto-YbbR peptides
                                               DACM-mCoA 11 TAMRA-mCoA 12 probes evaluated FRET
NIH-PA Author Manuscript




                                               characteristics FITC-YbbR 8.   DACM-mCoA 11 acts FRET donor FITC-YbbR
                                               8. (B) Excitation emission spectra probes 11 8 recorded normalized                                                determine spectral overlap 11 emission 8 excitation calculate overlap integral
                                               J(λ) [Eq. (3)] theoretical Forster’s radius R0 [Eq. (2)]  Summation                                                normalized data gave J(λ) 1.60 × 10−13cm4 R0 =38Å. (C) FRET characterization                                                crypto-DACM-FITC-YbbR peptide. Equimolar solutions 11 8 prepared                                                varying degree modification crypto-DACM-FITC-YbbR 7, fluorescent
                                               spectra recorded excitation 403nm. spectra overlayed, increase 10 
                                               increments modification 0 100 ; starting maximal emission observed                                                462nm minimum wavelength. (D) Eq. (5) fitted emission data (C)                                                gave efficiency transfer value 0.82. (E) FITC-YbbR 8 acts FRET donor                                                TAMRA-mCoA 12. (F) Excitation emission spectra probes 11 12 recorded
                                               normalized determine spectral overlap 11 emission 12 excitation calculate
                                               overlap integral J(λ) [Eq. (3)] theoretical Forster’s radius R0 [Eq. (2)] 
                                               Summation normalized data gave J(λ,) 3.01 × 10−13cm4 R0 =56Å. (G) FRET
                                               characterization crypto-TAMRA-YbbR peptide. Equimolar solutions 11 12                                                prepared varying degree modification crypto-TAMRA-YbbR 7,                                                fluorescent spectra recorded excitation 475nm. spectra overlayed, increase
NIH-PA Author Manuscript




                                               10  increments modification 0 100 ; starting maximal emission
                                               observed 513nm spectrum minimum value wavelength.
                                               (H) Eq. (5) fitted emission data 513nm (G) gave efficiency transfer
                                               value 0.99.




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                          Page 16
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               Fig. 5. Reaction progress enzyme titration
                                                 Reaction progress plots concentrations AcpS. Rates determined                                                experiments intersect dashed threshold 32,000 RFU. (B) Reaction rates                                                progress curves plotted AcpS concentration demonstrate linear
                                               response. (C) Reaction progress curves concentrations Sfp. Rates determined
                                               experiments intersect dashed threshold 32,000 RFU. (D) Reaction rates
                                               progress curves C plotted Sfp concentration demonstrate linear
                                               response.
NIH-PA Author Manuscript




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                               Page 17
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               Fig. 6. Determination analysis timepoint 
                                                 Progress curve 96 plate containing 48 reactions presense (?) absence
                                               (▪) 50 nM AcpS data timepoint analysed statistically presented                                                Table 2. 24 minute time point selected routine analysis, gave acceptable assay
                                               statistics linear range screen. (B) Change relative fluorescence units                                                24 minute time point (Table 2, boxed data) plotted number.  value                                                data 0.72. (C) Progress curve 96 plate containing 48 reactions presense
                                               (?) absence (▪) 12.5 nM Sfp. data timepoint analysed statistically                                                presented Table 2. 16 minute time point selected routine analysis, gave
                                               acceptable assay statistics linear range screen. (B) Change relative
                                               fluorescence units 16 minute time point (Table 2, boxed data) plotted                                                number.  value data 0.71.
NIH-PA Author Manuscript




                                                  Anal Biochem. Author manuscript; available PMC 2010 November 1.
                            Foley Burkart                                                                                       Page 18
NIH-PA Author Manuscript




                                               Fig. 7. Reproducibility IC50 values 3’-phosphoadenosine-5’-phosphate
                                                 Sfp screened 12 concentrations PAP ranging 244 nM 500 µM                                                separate days. data fit parameter dose response curve using
                                               GraphPad returned IC50 values 13, 11, 13 µM. (B) Replication                                                experiment ) using AcpS enzyme. curves returned IC50 values 86,
                                               